# Influence of the Severity of Infective Endocarditis on Long-Term Outcomes After Mitral Valve Surgery

**Authors:** Tadashi Omoto, Atsushi Aoki, Kazuto Maruta, Akitoshi Takazawa, Tomoaki Masuda

PMC · DOI: 10.7759/cureus.87934 · 2025-07-14

## TL;DR

This study shows that the severity of infective endocarditis impacts long-term outcomes after mitral valve surgery, with less severe cases having better survival and fewer complications.

## Contribution

The study introduces a severity score to assess infective endocarditis and demonstrates its impact on long-term surgical outcomes.

## Key findings

- Patients with low severity scores had a 100% 10-year survival rate compared to 70% for high severity cases.
- Mitral valve repair was more frequently performed in low severity cases and was associated with no recurrence of mitral regurgitation.
- High severity cases had more concomitant aortic valve operations and lower feasibility for mitral valve repair.

## Abstract

Objectives: Previous studies have demonstrated the advantages of mitral valve repair (MVP) in infective endocarditis (IE) in early and late outcomes. However, the influence of complexity in mitral valve surgery on long-term outcome is unclear. The purpose of this study was to clarify whether the severity of IE affects long-term outcome.

Methodology: Fifty-one patients who underwent mitral valve surgery during the active phase of native IE were retrospectively reviewed. Severity score was used as an index for the severity of IE. Severity score assigns a score derived from two aspects: (1) the extent of valvular destruction and (2) technical difficulties for predicting the feasibility of MVP reported by our previous studies. Patient profile, long-term survival, and freedom from recurrence of mitral regurgitation (MR) were compared between those with a severity score of 7 or less (low score: n = 17) and with a severity score of 8 or more (high score: n = 34). Recurrence of MR was defined as a more than moderate grade of MR.

Results: Body weight was lower and body surface area was smaller in high score, and concomitant aortic valve operation was more frequently performed in high score than in low score. MVP was more frequently performed in low score than in high score (88% vs. 38%, P < 0.001), and patients in low score showed a better 10-year survival rate than those in high score (100% vs. 70%; log-rank, P = 0.020). Freedom from recurrence of MR in 10 years after MVP was 100% vs. 53% in low score and high score, respectively (P = 0.008).

Conclusions: Severity of IE is associated with long-term outcome. Patients with low severity have high feasibility of MVP, low risks of reoperation, and good long-term survival. In patients with high severity, the indication for complex repair should be considered, taking age and future redo surgery into consideration.

## Linked entities

- **Diseases:** infective endocarditis (MONDO:0000565)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** cerebral infarction (MESH:D002544), renal failure (MESH:D051437), A2 lesion (MESH:C537089), leakage (MESH:D003763), systolic (MESH:D000092244), infection (MESH:D007239), intracranial bleeding (MESH:D013345), infective valvular and subvalvular lesions (MESH:D006349), leaflet defect (MESH:D000013), Endocarditis (MESH:D004696), calcification (MESH:D002114), vegetation (MESH:D018458), left ventricular rupture (MESH:D012421), respiratory failure (MESH:D012131), congestive heart failure (MESH:D006333), ischemia (MESH:D007511), gastrointestinal bleeding (MESH:D006471), pneumonia (MESH:D011014), MR (MESH:D008944), myocardial infarction (MESH:D009203), lesion (MESH:D009059), fever (MESH:D005334), aortic stenosis (MESH:D001024), AML (MESH:D015470), gastrointestinal complications (MESH:D005767), embolic events (MESH:D004617), obstructive lung disease (MESH:D008173), peritonitis (MESH:D010538), death (MESH:D003643), degenerative (MESH:D019636), anterior mitral leaflet (MESH:D008946)
- **Chemicals:** MVP (-), methicillin (MESH:D008712), creatine (MESH:D003401)
- **Species:** Cardiobacterium hominis (species) [taxon 2718], Gemella haemolysans (species) [taxon 1379], Enterococcus faecalis (species) [taxon 1351], Granulicatella adiacens (species) [taxon 46124], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12349976/full.md

---
Source: https://tomesphere.com/paper/PMC12349976